Fintech PR
CDNetworks Unveils Global-to-China Solution to Facilitate Business Entry into China for Multinational Corporations
With its Asia No.1 CDN Performance and one-stop services, CDNetworks is uniquely positioned to help multinational corporations win online business in China markets.
SINGAPORE, Nov. 16, 2023 /PRNewswire/ — CDNetworks, the APAC-leading network to deliver edge as a service, announces the introduction of its Global-to-China solution. This innovative solution provides multinational corporations with rapid entry into the China market by providing one-stop services that encompass local business startup, MLPS (Multi-Level Protection Scheme) & data security consultancy, performance optimization, security deployment and other additional services.
Recognizing the disparity between the enormous growth potential within China’s thriving economy and the challenges faced by multinational corporations trying to enter the Chinese market, CDNetworks’ Global-to-China solution bridges the gap by providing multinationals with the one-stop tool they need for rapid entry into the China market. By leveraging our all-in-one solution, multinationals can overcome challenges such as adapting to China’s unique network characteristics, adhering to strict regulations, and addressing network security risks with ease, enabling them to rapidly penetrate the market and seize competitive advantages.
“CDNetworks has a deep understanding of the various challenges that companies face when entering the Chinese market and provides comprehensive support to empower multinationals to work toward the best possible business outcomes in their target markets,” said Doyle Deng, Head of Global Marketing and Product at CDNetworks. “CDNetworks’ portfolio of products and services provide corporations with unparalleled advantages, starting from the preparation stage, before they enter China, to initial entry into the China market and through the continued growth of business in China.”
Highlights of CDNetworks Global-to-China Solution
- Rapid Business Startup: To quickly establish the foundation for online business in China, corporations typically need to complete an ICP filing, establish internal network connectivity, and implement a secure and robust network architecture for remote access within their organization.
CDNetworks’ Global-to-China solution not only helps corporations complete their ICP filing using end-to-end registration services, but also enables close collaboration between headquarters, branch offices, and even supply chain partners by leveraging technologies such as SD-WAN and zero trust to accelerate business startup. - Sustainable Business Continuity: CDNetworks understands the complexities of compliance and security challenges for corporations that want to enter the China market. That’s why this new Global-to-China solution has been designed from the ground up to address multidimensional and long-term consultancy services.
Using MLPS 2.0 filing as an example, CDNetworks can provide multinational corporations with a full lifecycle consulting service that fits the MLPS declaration process in China. When it comes to data security compliance filing, CDNetworks also offers comprehensive data security consulting services. By assisting multinationals to classify their data and conduct security assessments on storing, processing, and transmitting data, CDNetworks can propose remediation plans and suggestions at various lifecycle stages to help businesses identify vulnerabilities, fix gaps, and reduce operational risks before business operations begin. Overall, these consulting services provide great convenience to multinationals who are not familiar with relevant Chinese regulations, saving them considerable time and effort while avoiding the risk of business interruptions. - Enhanced Business Performance: With coverage in over 270 cities worldwide and more than 2800 Points of Presence (PoPs), CDNetworks consistently ranks first in Asia when it comes to CDN performance. Backed by robust delivery and back-to-origin routing capabilities for corporations located inside and outside China, CDNetworks offers unsurpassed content delivery services for multinationals.
CDNetworks partners with all ISPs in China and achieves 100% network coverage, high cache hit ratios, and nearly 0% packet loss consistently through PoPs located in over 140 cities in China. This unique synergy enables CDNetworks to provide low latency and high-quality content delivery services, ensuring that nearly all user requests are responded to within China. If a cross-border back-to-origin request is required, CDNetworks uses advanced technologies and tools such as intelligent routing, direct line, and self-developed private transmission protocols to ensure that relevant requests are always delivered over optimum paths, using the fastest route and speed available between the origin server and users to ensure smooth data flow and deliver an excellent user experience. - Effective Business Protection: To effectively protect business operations, the CDNetworks Global-to-China solution can provide multi-level security measures. Using WAAP capabilities, including DDoS Protection, Bot Management, WAF, and API Protection, CDNetworks can effectively safeguard multinational websites and applications from a wide range of cyberthreats, making it possible to crack down effectively on malicious users without impacting legitimate users or interrupting business operations in China. Additionally, CDNetworks’ zero trust solution, Enterprise Secure Access, secures remote access for enterprises, preventing data breaches that can damage brand value, impact the bottom line, leak sensitive information, threaten consumer trust, ruin reputations, and incur contractual, regulatory, and legal fines.
CDNetworks streamlines the process for multinational corporations seeking entry into the China market by offering a comprehensive suite of services through the Global-to-China Solution. This all-in-one solution not only facilitates the initial setup and entry into the market, but also extends support to ensure sustainable and long-term business success. By offering a range of additional solutions and services such as Cloud Computing, Edge Computing, Hybrid Cloud Management, and Major Event Support, CDNetworks shows its commitment to helping companies achieve operational efficiencies, security, and growth in the ever-evolving digital landscape of China.
For more details about our Global-to-China solutions, and to fully leverage the rapid growth opportunities in China, please click the following link: https://bit.ly/3ueEfEs
About CDNetworks
As the APAC-leading network with over 2,800 global Points of Presence and more than 20 years of technology experience, CDNetworks embraces the new era of Edge and takes it to the next level by using the Edge as a service to deliver the fastest and most secure digital experiences to end users. Our diverse products and services include web performance, media delivery, cloud security, zero trust security, and colocation services – all of which are uniquely designed to spur business innovation. To learn more, visit cdnetworks.com and follow us on LinkedIn.
Media Contact
CDNetworks Co. Ltd
[email protected]
www.cdnetworks.com
Logo – https://mma.prnewswire.com/media/1736512/LOGO_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cdnetworks-unveils-global-to-china-solution-to-facilitate-business-entry-into-china-for-multinational-corporations-301989290.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News4 days ago
Trina Storage Recognized as Tier 1 Energy Storage Manufacturer by BNEF for Second Consecutive Quarter
-
Latest News4 days ago
Bank of Spain grants Amadeus’ Outpayce EMI licence
-
Latest News4 days agoGenome and Chilli Partners join forces to revolutionize iGaming affiliate payouts
-
Latest News4 days ago
Newmark Reports First Quarter 2024 Financial Results
-
Latest News4 days ago
EQT to acquire WSO2, a leading global provider of digital transformation technologies
-
Latest News4 days ago
Lunar Poised for Nationwide Rollout in Sweden After Securing €24.1 Million in Funding
-
Latest News4 days ago
REALTY ONE GROUP CELEBRATES 19TH ANNIVERSARY WITH GLOBAL ‘ONE DAY’ OF VOLUNTEERING & GIVING BACK
-
Latest News4 days ago
BIZCLIK MEDIA LAUNCHES MAY EDITION OF FINTECH MAGAZINE
